Cargando…

Importance of predicting non-response to intravenous immunoglobulin therapy in non-Asian patients with Kawasaki disease

Detalles Bibliográficos
Autores principales:	Koné-Paut, Isabelle, Piram, Maryam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465312/ https://www.ncbi.nlm.nih.gov/pubmed/36106336 http://dx.doi.org/10.1016/j.lanepe.2022.100507

Ejemplares similares

Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease
por: Piram, Maryam, et al.
Publicado: (2020)

Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin
por: Galeotti, Caroline, et al.
Publicado: (2010)

Is it Kawasaki shock syndrome, Kawasaki-like disease or pediatric inflammatory multisystem disease? The importance of semantic in the era of COVID-19 pandemic
por: Koné-Paut, Isabelle, et al.
Publicado: (2020)

IL-1 Inhibition May Have an Important Role in Treating Refractory Kawasaki Disease
por: Dusser, Perrine, et al.
Publicado: (2017)

Intravenous immunoglobulin therapy for COVID-19 ARDS
por: Wilfong, Erin M, et al.
Publicado: (2022)

Prediction of Resistance to Standard Intravenous Immunoglobulin Therapy in Kawasaki Disease
por: Lee, Sang Min, et al.
Publicado: (2014)

Critical Overview of the Risk Scoring Systems to Predict Non-Responsiveness to Intravenous Immunoglobulin in Kawasaki Syndrome
por: Rigante, Donato, et al.
Publicado: (2016)

Epidemiology of Kawasaki Disease in Europe
por: Piram, Maryam
Publicado: (2021)

Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease
por: Park, Hyo Min, et al.
Publicado: (2013)

Intravenous immunoglobulin for the treatment of Kawasaki disease
por: Broderick, Cathryn, et al.
Publicado: (2023)

Still’s Disease in the Constellation of Hyperinflammatory Syndromes: A Link with Kawasaki Disease?
por: Dusser, Perrine, et al.
Publicado: (2021)

Thrombospondin-2 predicts response to treatment with intravenous immunoglobulin in children with Kawasaki disease
por: Yang, Shuai, et al.
Publicado: (2018)

Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease
por: Lu, Yaheng, et al.
Publicado: (2021)

Non-Responders to Intravenous Immunoglobulin and Coronary Artery Dilatation in Kawasaki Disease: Predictive Parameters in Korean Children
por: Kim, Bo Young, et al.
Publicado: (2016)

Maladie de Kawasaki()
por: Marsaud, C., et al.
Publicado: (2018)

The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?
por: Han, Ji Whan
Publicado: (2017)

Steroids or intravenous immunoglobulin as first line in MIS-C in LMICs
por: Crosby, Laura, et al.
Publicado: (2021)

The expanding spectrum of rare monogenic autoinflammatory diseases
por: Touitou, Isabelle, et al.
Publicado: (2013)

Factors Predicting Resistance to Intravenous Immunoglobulin and Coronary Complications in Kawasaki Disease: IVIG Resistance in Kawasaki Disease
por: Han, Ji Whan
Publicado: (2017)

Low-dose Methotrexate Therapy for Intravenous Immunoglobulin-resistant Kawasaki Disease
por: Lee, Taek Jin, et al.
Publicado: (2008)

Editorial: Pathogenesis, Clinical Findings, and Treatment Advances in Kawasaki Disease
por: Giani, Teresa, et al.
Publicado: (2021)

Health-related quality of life in children with PFAPA syndrome
por: Grimwood, Claire, et al.
Publicado: (2018)

Predictors and management of intravenous immunoglobulin-resistant Kawasaki disease
por: Song, Min Seob
Publicado: (2019)

Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease
por: Li, Wei, et al.
Publicado: (2022)

Intravenous Immunoglobulin in Kawasaki Disease—Evolution and Pathogenic Mechanisms
por: Nadig, Pallavi L., et al.
Publicado: (2023)

Predisposing factors, pathogenesis and therapeutic intervention of Kawasaki disease
por: Galeotti, Caroline, et al.
Publicado: (2016)

Predictive factors of resistance to intravenous immunoglobulin and coronary artery lesions in Kawasaki disease
por: Lee, Hye Young, et al.
Publicado: (2016)

Intravenous immunoglobulin resistance in Kawasaki disease patients: prediction using clinical data
por: Lam, Jonathan Y., et al.
Publicado: (2023)

Parameters to Guide Retreatment After Initial Intravenous Immunoglobulin Therapy in Kawasaki Disease
por: Kim, Hyun Kwon, et al.
Publicado: (2011)

Efficacy of Glucocorticoid plus Intravenous Immunoglobulin in Children with Immunoglobulin-Insensitive Kawasaki Disease
por: Ma, Yongmei, et al.
Publicado: (2022)

White Blood Cell and Neutrophil Counts and Response to Intravenous Immunoglobulin in Kawasaki Disease
por: Muto, Taichiro, et al.
Publicado: (2019)

Hemolysis From Intravenous Immunoglobulin in Obese Patients With Kawasaki Disease
por: Van Anh, Khanh-Van Y., et al.
Publicado: (2020)

Intravenous Immunoglobulin Treatment in Kawasaki Disease Decreases the Incidence of Myopia
por: Yu, Hun-Ju, et al.
Publicado: (2021)

Retracted: Efficacy of Glucocorticoid plus Intravenous Immunoglobulin in Children with Immunoglobulin-Insensitive Kawasaki Disease
por: Healthcare Engineering, Journal of
Publicado: (2023)

Plasma Clusterin Concentrations May Predict Resistance to Intravenous Immunoglobulin in Patients with Kawasaki Disease
por: Ou-Yang, Mei-Chen, et al.
Publicado: (2013)

Meta-analysis of factors predicting resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease
por: Baek, Jin-Young, et al.
Publicado: (2016)

A comparison of efficacy of six prediction models for intravenous immunoglobulin resistance in Kawasaki disease
por: Qian, Weiguo, et al.
Publicado: (2018)

Neutrophil-to-lymphocyte ratio as a biomarker for predicting the intravenous immunoglobulin-resistant Kawasaki disease
por: Wu, Gang, et al.
Publicado: (2020)

Risk Factors and Predictive Models for Intravenous Immunoglobulin Resistance in Children with Recurrent Kawasaki Disease
por: Chen, Xi, et al.
Publicado: (2022)

A tribute to Dr. Tomisaku Kawasaki (7 February 1925–5 June 2020)
por: Koné-Paut, I.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o2k2b81f2jgtep9qgn3dv5m4n3